Clinique des 3 cyprès
La Penne-sur-Huveaune, 13821, France
NCT Number: NCT07020013
The objective of the study is to evaluate the benefit of day care in a child psychiatric hospital on the return to school and on the development of child psychiatric disorders associated with Anxious Social Refusal.
Trial opening soon.
Get Notified12 year–18 year
All sexes
Observational
La Penne-sur-Huveaune, 13821, France
This is a prospective, longitudinal, single-center observational cohort study carried out on a population of patients followed in a day hospital for anxious school refusal.
Participating physicians will have the opportunity to recruit their patients over a 12-month period. All enrolled patients will be followed for a minimum of 10 months. The study will be completed as soon as the last enrolled patient has completed a final assessment.
Aside from the baseline visit, each patient will be assessed only once at 10 months. During each patient visit with the investigating physician, the physician will complete an assessment on the electronic CRF.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Month 10
The primary endpoint is based on the change in the SCREEN scale score between inclusion and the end of the study. A 20% improvement in this score will be considered as evidence of a benefit from day hospital care on anxious school refusal.
Time frame: Month 10
The Yale-Brown Obsession-Compulsion Scale (CY-BOCS) is a structured interview that provides an assessment of the severity of obsessive-compulsive symptoms unbiased by the presence or absence of a particular type of obsession or compulsion.
Time frame: Month 10
The Spence Children's Anxiety Scale (SCAS) is a 44-item self-report questionnaire. Each item is rated on a 4-point Likert scale, from 0 (never) to 3 (always). No time period is specified for the scope of the questions.
Six of the 44 items are positive items intended to limit the tendency to respond negatively; they are not included in the overall score.
The overall score, obtained by adding all 38 items, ranges from 0 to 144. The questionnaire identifies six dimensions of anxiety: Panic Attack and Agoraphobia, Separation Anxiety, Fear of Physical Injury, Social Phobia, OCD, and Generalized Anxiety Disorder.
Time frame: Month 10
The Children's Depression Rating Scale - Revised (CDRS) is a revised version of a questionnaire originally derived from the Hamilton Rating Scale for Depression. The total score is an index of the intensity of depressive symptomatology in children aged 6 to 12 years. It is a 17-item, self-assessment tool, completed by a clinician based on a non-directive interview with the child, and supplemented or corrected, based on clinical judgment, with additional information from the family or teachers.
Time frame: Month 10
The UCLA Child/Adolescent Posttraumatic Stress Disorder Reaction Index was designed for use with school-aged children and adolescents. The DSM-5 version is a semi-structured interview with a clinician that assesses a child's trauma history and the full range of DSM-5 symptoms and diagnostic criteria for posttraumatic stress disorder. This measure consists of several parts: an assessment of different types of trauma, a DSM-5 posttraumatic stress disorder symptom scale including dissociative symptoms, and an assessment of distress and impairment.
Time frame: Month 10
The ADHD Rating Scale is a specific assessment tool for ADHD. Consisting of the 18 clinical symptoms involved in diagnosing the disorder in the DSM-IV, it quantifies the severity of the disorder and assesses the various dimensions of the disorder (hyperactivity, inattention, and impulsivity). In most clinical studies, a score of 28 or higher is required to qualify ADHD as significant.
Time frame: Month 10
Current schooling method (or planned in the short term) at month 10
Contact information is provided by the study sponsor or research team.
GCS Ramsay Santé pour l'Enseignement et la Recherche
Other
Acronym: REPECH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05432323
Anxiety Disorders, Mental Disorders
Paris, IDF, France
View Trial DetailsNCT03288649
Anorexia Nervosa, Anxiety Disorders
Argenteuil, France
View Trial DetailsNCT05647499
Absence, Anxiety Disorders
Bergen, Norway
View Trial DetailsNCT03459677
Anxiety Disorders, Anxiety Symptoms
Aarhus, Denmark
View Trial Details